372 related articles for article (PubMed ID: 8377751)
1. [Treatment of sepsis by extracorporeal elimination of endotoxin using fiber-immobilized polymyxin B].
Aoki H; Tani T; Hanasawa K; Shoji H; Kodama M
Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):775-80. PubMed ID: 8377751
[TBL] [Abstract][Full Text] [Related]
2. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber.
Aoki H; Kodama M; Tani T; Hanasawa K
Am J Surg; 1994 Apr; 167(4):412-7. PubMed ID: 8179086
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
[TBL] [Abstract][Full Text] [Related]
4. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
Nakamura T; Sugaya T; Koide H
Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
[TBL] [Abstract][Full Text] [Related]
5. [Endotoxin eliminating therapy in patients with severe sepsis--direct hemoperfusion using polymyxin B immobilized fiber column].
Kodama M; Tani T; Maekawa K; Hirasawa H; Otsuka T; Takahashi Y; Kaneko M
Nihon Geka Gakkai Zasshi; 1995 May; 96(5):277-85. PubMed ID: 7596338
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock.
Shoji H; Opal SM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672437
[TBL] [Abstract][Full Text] [Related]
7. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
Mitaka C; Tomita M
Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application.
Shoji H; Tani T; Hanasawa K; Kodama M
Ther Apher; 1998 Feb; 2(1):3-12. PubMed ID: 10227782
[TBL] [Abstract][Full Text] [Related]
9. Polymyxin-B hemoperfusion and endotoxin removal: lessons from a review of the literature.
Cruz DN; de Cal M; Piccinni P; Ronco C
Contrib Nephrol; 2010; 167():77-82. PubMed ID: 20519901
[TBL] [Abstract][Full Text] [Related]
10. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal removal of endotoxin: the polymyxin B-immobilized fiber cartridge.
Tani T; Shoji H; Guadagni G; Perego A
Contrib Nephrol; 2010; 167():35-44. PubMed ID: 20519897
[TBL] [Abstract][Full Text] [Related]
12. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
Nakamura T; Suzuki T; Kawagoe Y; Koide H
ASAIO J; 2008; 54(2):210-3. PubMed ID: 18356658
[TBL] [Abstract][Full Text] [Related]
13. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
[TBL] [Abstract][Full Text] [Related]
14. Effect of direct hemoperfusion using polymyxin B immobilized fiber on inflammatory mediators in patients with severe sepsis and septic shock.
Kanesaka S; Sasaki J; Kuzume M; Narihara K; Takahashi Y
Int J Artif Organs; 2008 Oct; 31(10):891-7. PubMed ID: 19009507
[TBL] [Abstract][Full Text] [Related]
15. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock.
Mitaka C; Tsuchida N; Kawada K; Nakajima Y; Imai T; Sasaki S
Shock; 2009 Nov; 32(5):478-83. PubMed ID: 19295483
[TBL] [Abstract][Full Text] [Related]
16. Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period.
Mitaka C; Fujiwara N; Yamamoto M; Toyofuku T; Haraguchi G; Tomita M
J Crit Care; 2014 Oct; 29(5):728-32. PubMed ID: 24798345
[TBL] [Abstract][Full Text] [Related]
17. The severity of hyperdynamic circulation may predict the effects of direct hemoperfusion with the adsorbent column using polymyxin B-immobilized fiber in patients with gram-negative septic shock.
Uriu K; Osajima A; Kamochi M; Watanabe H; Aibara K; Kaizu K
Ther Apher; 2001 Feb; 5(1):25-30. PubMed ID: 11258606
[TBL] [Abstract][Full Text] [Related]
18. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
[TBL] [Abstract][Full Text] [Related]
19. Endotoxin removal by polymyxin B immobilized cartridge inactivates circulating proapoptotic factors.
Martin EL; Ranieri VM
Contrib Nephrol; 2010; 167():65-76. PubMed ID: 20519900
[TBL] [Abstract][Full Text] [Related]
20. Clinical effects of polymyxin B-immobilized fiber column in septic patients.
Cruz DN; Bellomo R; Ronco C
Contrib Nephrol; 2007; 156():444-51. PubMed ID: 17464156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
